Infection of T cell subsets by HIV-1 and the effects of interleukin-12

Journal of Interferon and Cytokine Research

Volumn 18, Issue 7, 1998, Pages 521-528

  Salgame, P ^a   Guan, M X ^a   Agahtehrani, A ^a   Henderson, E E ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; RNA DIRECTED DNA POLYMERASE; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME ACTIVITY; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; LYMPHOCYTE CLONE; PRIORITY JOURNAL; SYNCYTIUM; VIRUS REPLICATION;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0031902101     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1998.18.521     Document Type: Article

References (41)

1. FAUCI, A. (1993). Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262, 1011-1018.
2. CLERICI, M., STOCKS, N.I., ZAJAC, R.A., BOSWELL, R.N., LUCEY, D.R., VIA, C.S., and SHEARER, G.M. (1989). Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, HIV-seropositive patients. J. Clin. Invest. 84, 1892-1899.
3. MOSMANN, T.R., and COFFMAN, R.L. (1989). Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173.
4. + T cell specificity and function. Immunol. Rev. 101, 39-80.
5. SALGAME, P., ABRAMS, J., CLAYBERGER, C., GOLDSTEIN, H., CONVIT, J., MODLIN, R., and BLOOM, B.R. (1991). Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254, 279-282.
6. ROMAGNANI, S. (1994). Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12, 227-257.
7. + T lymphocytes in atopic patients. J. Immunol. 144, 4651-4656.
8. SALGAME, P.R., YAMAMURA, M., BLOOM, B.R., and MODLIN, R.L. (1992). In: Regulation and Functional Significance of T-Cell Subsets. R.L. Coffman (ed.) Basel, Switzerland: Karger, pp. 44-59.
9. BLOOM, B.R., SALGAME, P., and DIAMOND, B. (1992). Revisiting and revising T suppressor cells. Immunol. Today 13, 131-136.
10. BLOOM, B.R., MODLIN, R.L., and SALGAME, P. (1992). Stigma variations: observations on suppressor T cells and leprosy. Annu. Rev. Immunol. 10, 453-488.
11. HEINZEL, F.P., SADICK, M.D., HOLADAY, B.J., COFFMAN, R.L., and LOCKSLEY, R.M. (1989). Reciprocal expression of interferon-γ or interleukin-4 during the resolution or progression of murine leishmania. J. Exp. Med. 169, 59.
12. + T cells. Annu. Rev. Immunol. 12, 635-673.
13. + T cells in the peripheral blood leukocytes of asymptomatic HIV carriers in vitro. J. Virol. 64, 3399-3406.
14. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 234, 1563-1566.
15. + cells involves a non-cytolytic mechanism. J. Virol. 65, 5921-5927.
16. CLERICI, M., and SHEARER, G.M. (1993). A Th1 to Th2 switch is a critical step in the etiology of HIV infection. Immunol. Today 14, 107-111.
17. GRAZIOSI, C., PANTALEO, G., GANTT, K.R., FORTIN, J.-P., DEMAREST, J.F., COHEN, O.J., SEKALY, R.P., and FAUCI, A.S. (1994). Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science 265, 248-252.
18. MAGGI, E., MEZZETTI, M., RAVINA, A., ANNUNZIATO, F., DE CARLI, M., PICCINNI, M.P., MANETTI, R., CARBONARI, M., PESCE, A.M., DEL PRETE, G., and ROMAGNANI, S. (1994). Ability of HIV to promote Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 265, 244.
19. VARADHACHARY, A., PERDOW, S., HU, C., RAMANARAYANAN, M., and SALGAME, P. (1997). Differential ability of T cell subsets to undergo activation-induced cell death. Proc. Natl. Acad. Sci. USA 94, 5778-5783.
20. + T cells from human immunodeficiency virus-infected persons. J. Exp. Med. 182, 1759-1767.
21. CLERICI, M., SARIN, A., COFFMAN, R.L., WYNN, T.A., BLATT, S.P., HENDRIX, C.W., WOLF, S.F., SHEARER, G.M., and HENKART, P.A. (1994). Type1/type2 cytokine modulation of T-cell programmed cell death as a model for human immunodeficiency virus pathogenesis. Proc. Natl. Acad. Sci. USA 91, 11811-11815.
22. CLERICI, M., LUCEY, D.R., BERZOFSKY, J.A., PINTO, L.A., WYNN, T.A., BLATT, S.P., DOLAN, M.J., HENDRIX, C.W., WOLF, S.F., and SHEARER, G.M. (1993). Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 262, 1721-1724.
23. CHEHIMI, J., STARR, S.E., FRANK, I., D'ANDREA, A., MA, X., MACGREGOR, R.R., SENNELIER, J., and TRINCHIERI, G. (1994). Impaired interleukin-12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179, 1361-1366.
24. ZHANG, R.-D., GUAN, M., PARK, Y., TAWADROS, R., YANG, J.-Y., GOLD, B., WU, B., and HENDERSON, E.E. (1997). Synergy between human immunodeficiency virus type 1 (HIV-1) and Epstein-Barr virus in T lymphoblastoid cell lines. AIDS Res. Hum. Retrovir. 13, 161-171.
25. SALGAME, P.R., MODLIN, R.L., and BLOOM, B.R. (1989). On the mechanism of human T cell suppression. Int. Immunol. 1, 121-129.
26. VYAKARNAM, A., MATEAR, P.M., MARTIN, S.J., and WAGSTAFF, M. (1995). Th1 cells specific for HIV-1 gag p24 are less efficient than Th0 cells in supporting HIV replication, and inhibit virus replication in Th0 cells. Immunology 86, 85-96.
27. VICENZI, E., and POLI, G. (1994). Regulation of HIV expression by viral genes and cytokines. J. Leukocyte Biol. 56, 328-334.
28. OSBURN, L., KUNKEL, S., and NABEL, G.J. (1989). Tumor necrosis factor-α and interleukin 1 stimulate the human immunodeficiency virus in a chronically infected T-cell clone. Proc. Natl. Acad. Sci. USA 86, 2336-2340.
29. DUH, E.J., MAURY, W.J., FOLKS, T.M., FAUCI, A.S., and RABSON, A.B. (1989). Tumor necrosis factor alpha activates human immunodeficiency virus enhancer by activation of the nuclear factor κB. Proc. Natl. Acad. Sci. USA 86, 5974-5978.
30. TRINCHIERI, G. (1995). In: The two faces of interleukin 12: a pro-inflammatory cytokine and a key immunoregulatory molecule produced by antigen-presenting cells. Cell Subsets in Infectious and Autoimmune Diseases. Chichester, UK (Ciba Foundation Symposium): Wiley, 195, 203-224.
31. YOO, J., CHEN, H., KRAUS, T., HIRSCH, D., POLYAK, S., GEORGE, I., and SPERBER, K. (1996). Altered cytokine production and accessory cell function after HIV-infection. J. Immunol. 157, 1313-1320.
32. NAKASHIMA, H., YOSHIDA, T., HARADA, S., and YAMAMOTO, S. (1986). Recombinant human interferon gamma suppresses HTLV-III replication in vitro. Int. J. Cancer 38, 433-436.
33. WONG, G.H.W. (1988). In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-α and interferon-γ. J. Immunol. 140, 120-124.
34. KORNBLUTH, R.N., OH, P.S., MUNIS, J.R., CLEVELAND, P.H., and RICHMAN, D.D. (1989). Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro. J. Exp. Med. 169, 1137-1151.
35. ANTONI, B.A., STEIN, S.B., and RABSON, A.B. (1994). Regulation of human immunodeficiency virus infection: implications for pathogenesis. Adv. Virus Res. 43, 53-145.
36. CAO, Y., QIN, L., ZHANG, L., SAFRIT, J., and HO, D.D. (1995). Virologie and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 332, 201-208.
37. + T cells. Science 270, 1811-1815.
38. + lymphocytes from persons who remain uninfected despite multiple high-risk sexual exposures. Nature Med. 2, 412-417.
39. BATES, P. (1996). Chemokine receptors and HIV-1: an attractive pair? Cell 86, 1-3.
40. BLEUL, C.C., WU, L., HOXIE, J.A., SPRINGER, T.A., and MACKAY, C.R. (1997). The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc. Natl. Acad. Sci. USA 94, 1925-1930.
41. BONECCHI, R., BIANCHI, G., BORDIGNON, P.P., D'AMBROSIO, D., LANG, R., BORSATTI, A., SOZZANI, S., ALLAVENA, P., GRAY, P.A., MANTOVANI, A., and SINIGAGLIA, F. (1998). Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1) and Th2s. J. Exp. Med. 1, 129-134.